Metabolomic Profiling of Ashwagandha (Withania somnifera): Linking Bioactive Compounds to Functional Therapeutic Roles
Gaurav TripathiiD, Vasundhra Bindal, Sanju Yadav, Manisha YadaviD, Neha SharmaiD, Sushmita Pandey, Vipul Sharma, Nupur SharmaiD, Babu MathewiD, Yash Magar, Shvetank SharmaiD, Shiv Kumar SariniD, Jaswinder Singh MarasiD
Abstract
IntroductionWithania somnifera (Ashwagandha) is a widely used medicinal plant with established roles in traditional systems of medicine. Known for diverse pharmacological effects, including neuroprotection, hepatoprotection, enhancement of male fertility, and anti-inflammatory activity. Despite its longstanding use, a deeper understanding of its phytochemical composition and bioactive mechanisms is required to bridge traditional knowledge with modern therapeutic applications. MethodsA comprehensive metabolomics profiling of Withania somnifera was performed to identify and quantify its bioactive secondary metabolites. Focus was placed on major classes such as alkaloids, phenolic compounds, and terpenoids. Known compounds were annotated and categorized based on their abundance, chemical class, and reported biological functions. Particular attention was given to compounds implicated in neuroprotection, liver health, reproductive support, and inflammation-modulation. ResultsThe analysis revealed a rich but low-abundance of known metabolites. Alkaloids such as Gentianaine (8.44%) and Sauroxine (2.94%), and phenolics like Mulberrofuran A (14.58%) and Sulphuretin (9.61%), were among the most prominent. These compounds are associated with antioxidative, anti-inflammatory, and neuroregenerative activities. Terpenoids including Pinocarvone and Ergosterol contributed to hepatoprotective and anti-inflammatory properties. Compounds such as Gomphrenin-I, Sitosterol, Pfaffic acid, beta-Carotene and others (>3%) supported spermatogenesis, while Embelin and Kievitone enhanced oxidative stress response. Although most identified compounds were individually present in low percentages ( View larger version (25K): org.highwire.dtl.DTLVardef@1ae8e5forg.highwire.dtl.DTLVardef@105300corg.highwire.dtl.DTLVardef@1958320org.highwire.dtl.DTLVardef@d3ba13_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 40%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin
S. Dubey, M. Kallubai, … R. Subramanyam·bioRxiv·Jun 20, 2018
- The cytochrome P450 enzyme WsCYP71B35 from Withania somnifera has a role in withanolides biosynthesis and defense against bacteria
H. B. Shilpashree, A. K. Narayanan, … D. A. Nagegowda·bioRxiv·Oct 27, 2023
- Qualitative determination of bioactive metabolites of chyawanprash by using Gas Chromatography-Mass Spectroscopy
R. B. Komaragiri, M. S. T S, … N. U·bioRxiv·Oct 10, 2022
- HPLC analysis of Withania somnifera (Linn.) Dunal reveals two chemotypes in Indian germplasm and seasonal and genetic variability in Withaferin A -Content
N. Kaushik·bioRxiv·Jul 31, 2020
- Chemo-Profiling by UPLC-QTOF-MS, GC-MS/MS analysis and In Vitro Bioactivity Assessment of Desmodium gangeticum DC.
Mahendra Jagtap, Aditya B. Magdum, … Swaroopa Amit Patil·South African Journal of BotanyPeer-reviewed·Aug 13, 2025
- Widely targeted metabolomics analysis reveals differences in volatile metabolites among four Angelica species
J. j. Ji, L. l. Zang, … L. Wang·bioRxiv·Dec 1, 2022